Phreesia Partners with NAFC to Address Urinary Incontinence
Phreesia and NAFC Join Forces for Health Initiative
Phreesia, known for its innovative patient engagement solutions, is excited to announce a partnership with the National Association for Continence (NAFC) and Health.Equity.Outcomes. This collaborative effort aims to address the significant public health challenge of urinary incontinence (UI) among women, particularly acknowledging that this condition remains widely underdiagnosed and underreported.
The Importance of Addressing Urinary Incontinence
Urinary incontinence affects approximately 100 million women in the United States, yet it is rarely talked about. Many women live with this condition for years without seeking help, with studies revealing that only 1 in 4 ever consult a healthcare provider. The time between the onset of symptoms and the first professional consultation can stretch to as much as 6.5 years, leading to unnecessary physical and emotional distress.
Understanding the Impact on Women's Health
The effects of UI are profound. Factors such as pregnancy, childbirth, and menopause significantly contribute to the occurrence of incontinence in women. The prevalence increases as women age, with studies indicating that UI can impact up to 75% of women over the age of 65. Those affected may find their mental health declining and their social interactions reduced, often leading to isolation.
CDC Grant to Enhance Public Awareness
Recognizing the urgent need for action, the U.S. Centers for Disease Control and Prevention (CDC) has awarded a research grant to this initiative. The funding will support campaigns designed to raise awareness about UI, aiming to empower women to discuss their symptoms openly with healthcare professionals.
Promoting Evidence-Based Practices
Phreesia's digital patient engagement platform will be instrumental in this campaign. By allowing women an easy avenue to learn about UI as well as promoting discussions with their providers, the campaign will address the existing knowledge gaps. Additionally, the partnership plans to generate a report on UI prevalence that can help public health experts better understand and address the issue.
Goals and Future Initiatives
Key objectives of the initiative include providing educational material in clinical settings, developing informative surveys, and compiling evidence-based guidance on screening and treatment options for patients and healthcare providers. These efforts aim to foster better dialogue between patients and their healthcare teams.
Leadership Perspectives on the Initiative
David Linetsky, Senior Vice President at Phreesia, highlights the importance of patient empowerment: "If we can activate those with UI to speak with their providers, we can significantly enhance their health outcomes and overall quality of life." His sentiment emphasizes the core mission of Phreesia - to facilitate a patient-centered approach in healthcare.
Wider Implications of the Grant
With federal funding supporting this effort, project leaders like Sarah Jenkins from NAFC note that increased awareness can lead to better care practices, ultimately enhancing the quality of life for millions facing UI. The effects of untreated UI can deeply affect individuals, leading to emotional distress and reduced engagement with life.
Building on Community Innovations
The involvement of Health.Equity.Outcomes. brings additional commitment to enhancing community health initiatives. Sheila Fifer, a principal at HEO, expresses gratitude for the chance to add momentum to national efforts aimed at improving women's health, particularly in the context of UI.
Final Thoughts on the Initiative
Dr. Christina Escobar states the vision clearly, expressing commitment to generating new knowledge and awareness regarding UI. By leveraging this partnership, the hope is to not only raise awareness but also to equip healthcare providers with valuable insights to better assist women struggling with urinary incontinence.
Frequently Asked Questions
What is the main goal of the partnership between Phreesia and NAFC?
The partnership aims to tackle urinary incontinence by raising awareness and improving patient access to care through a CDC-funded initiative.
Why is urinary incontinence often underreported among women?
Many women feel embarrassed or unaware that help is available, leading to a significant gap in seeking medical advice for symptoms.
How will the grant funding be utilized?
The funding will support campaigns, educational efforts, and research initiatives focused on UI prevention and treatment.
What is the expected impact of this awareness campaign?
By educating and encouraging women to seek help, the campaign aims to reduce the stigma around UI and improve overall health outcomes.
How can women learn more about urinary incontinence?
Women can access educational resources provided by the partnership and consult with their healthcare providers for personalized care and support.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- CFO of IGM Biosciences Executes Stock Sale Amid Company Growth
- Neuralink's Blindsight Device: Restoring Vision Beyond Limits
- Chad Richison's Significant Stock Sale and Paycom's Financial Status
- Arcellx CFO Michelle Gilson Offloads Significant Stock Holdings
- Recent Developments of IGM Biosciences' Stock Performance
- CEO Fred Schwarzer's Recent Stock Sale and Market Insights
- Viatris Boosts Maximum Tender Offer to Enhance Financial Flexibility
- Investigation Underway for Adobe Inc. Investors Amid Concerns
- Investigation Announced for Customers Bancorp, Inc. Investors
- Investigation into Actinium Pharmaceuticals Inc. Raises Concerns
Recent Articles
- Investors Alert: Starbucks Corporation Faces Legal Action Opportunity
- Significant Shifts in Marijuana Stocks: September Update
- Axle Point Capital: Pioneering Investments in Defense Sector
- JPMorgan Chase Announces Dividend for Common Stockholders
- Crown LNG Faces Nasdaq Compliance Challenge on Stock Price
- Third Century Bancorp Shares Exciting News on Dividend Declaration
- Exploring Alcoa's Recent Options Activity and Market Insights
- Exploring Market Trends in British American Tobacco Options Trading
- Understanding Recent Options Activity at Redfin Corp (RDFN)
- Investors Can Join Legal Action Against Ardelyx, Inc. Now
- Investors Could Claim Losses in Five Below, Inc. Lawsuit
- Fulton Financial Corporation Announces Quarterly Dividend Details
- INOVIO Showcases Innovations at Major Scientific Conference
- Allison Transmission and LiuGong Collaborate for Mining Innovation
- GeoVax Labs Adjusts Meeting Plans, Sets New Date for Stockholders
- Roku Inc. Secures $300 Million Credit Facility for Growth
- Kytopen's Flowfect Tx™ Platform Sets New Standard for Cell Engineering
- Challenges Ahead for Dunxin Financial Following Delisting
- Lockheed Martin Secures $297M Contract for NOAA Lightning Mapper
- Mondee Boosts Growth Prospects with $15M Credit Secured
- MEM Enhances Midwest Operations with Exciting Brand Launch
- Cousins Properties Declares Q3 Dividend of $0.32 Per Share
- Truist Securities Increases Cintas Price Target to $225
- Guayakí Yerba Mate and LAFC Join Forces to Transform Soccer
- D-Market's Strategic Board Expansion Amidst Financial Decisions
- Aflac Donates 40 Special Ducks to Children’s Hospital Patients
- Interactive Strength Inc. Restructures Debt through Equity Swap
- Emergent BioSolutions Declares Strategic Equity Moves Today
- Capricor Therapeutics Boosts Market Confidence with New Deals
- Bridgette P. Heller's Recent Sell-off: Impacts on DexCom's Market
- Cytokinetics Executive Sells Stock Amid Positive Drug Developments
- Michael Davis Increases Stake in Cyanotech with $8,200 Purchase
- Air Industries Group Insider Transaction and Recent Developments
- Neurocrine Biosciences: Executive Stock Sale and Future Prospects
- IBEX Ltd Insider Transactions Highlight Financial Performance
- Steve Cohen Shifts Focus to Growth at Point72 Asset Management
- BlackRock and Microsoft Unite for a Major AI Investment Fund
- Introducing $BBT Token: Revolutionizing Blockchain Gaming Experience
- Indivior PLC Investors Can Now Seize Class Action Opportunity
- Understanding the Latest Developments with Transocean Ltd. RIG
- Biden Administration Plans Significant Oil Purchase to Replenish Reserves
- Emerie.ai: Transforming Customer Experience in FinTech
- Casella Waste Systems Initiates $400 Million Stock Offering
- RadNet, Inc. Showcases Innovations at Upcoming Virtual Conference
- Structure Therapeutics Enhances Leadership Team for Growth
- Resolute Holdings Expands Presence with CompoSecure Acquisition
- GOREWEAR Launches Innovative Lineup for Running and Cycling
- DXC Technology Company Investors Encouraged to Act Before Deadline
- Kairos Pharma Celebrates Successful $6.2 Million IPO
- Toll Brothers Declares Quarterly Dividend for Shareholders